Halime Kalkavan
Impact in
- Immunology top 10%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- interferon and immune responses
- Cancer Research top 10%
Papers in ⓘ
-
- Cell death mechanisms and regulation 5
- Oncology 6
- Cancer Cells and Metastasis 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Douglas R. Green (8 shared papers)Giovanni Quarato (3 shared papers)Jeremy Chase Crawford (3 shared papers)Patrick Fitzgerald (2 shared papers)Jinan Chen (2 shared papers)Colin R. Goding (2 shared papers)Stephen W. G. Tait (1 shared paper)Joseph T. Opferman (1 shared paper)
- Journals
- Cell (2 papers)Cellular Physiology and Biochemistry (2 papers)Genes & Development (1 paper)Cell Death and Differentiation (1 paper)Pigment Cell & Melanoma Research (1 paper)
- Partner nations
- United StatesGermanyCroatia
In The Last Decade
Halime Kalkavan
14 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 303
- Cancer Research 173
- Molecular Biology 719
- Epidemiology 256
- Physiology 32
Countries citing papers authored by Halime Kalkavan
This map shows the geographic impact of Halime Kalkavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halime Kalkavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halime Kalkavan more than expected).
Fields of papers citing papers by Halime Kalkavan
This network shows the impact of papers produced by Halime Kalkavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halime Kalkavan. The network helps show where Halime Kalkavan may publish in the future.
Co-authors
The 25 scholars most cited alongside Halime Kalkavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MOMP, cell suicide as a BCL-2 family business Hit paper breakdown → | 2017 | 511 |
| 2 | 2018 | 242 | |
| 3 | Sublethal cytochrome c release generates drug-tolerant persister cells Hit paper breakdown → | 2022 | 138 |
| 4 | 2023 | 53 | |
| 5 | 2022 | 45 | |
| 6 | 2018 | 36 | |
| 7 | 2014 | 36 | |
| 8 | 2023 | 27 | |
| 9 | 2019 | 25 | |
| 10 | 2015 | 18 | |
| 11 | 2016 | 9 | |
| 12 | 2016 | 5 | |
| 13 | 2011 | 4 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 0 | |
| 16 | 2025 | 0 |
About Halime Kalkavan
Halime Kalkavan is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Autophagy in Disease and Therapy (5 papers), Phagocytosis and Immune Regulation (3 papers), Cancer Cells and Metastasis (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metabolism and Genetic Disorders (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Immunology (303 citations), Cancer Research (173 citations), Molecular Biology (719 citations), Epidemiology (256 citations) and Physiology (32 citations). Halime Kalkavan has collaborated with scholars based in United States, Germany and Croatia. Frequent co-authors include Douglas R. Green, Giovanni Quarato, Jeremy Chase Crawford, Patrick Fitzgerald, Jinan Chen, Colin R. Goding, Stephen W. G. Tait, Joseph T. Opferman, Meghan E. Turnis and David Finkelstein. Their work appears in journals such as Cell, Cellular Physiology and Biochemistry, Genes & Development, Cell Death and Differentiation and Pigment Cell & Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.